Testing the Lumena — World’s 1st Aerosol-safe NIV Mask

In the process of testing the world’s first aerosol-safe non-invasive ventilation (NIV) mask, a freelance scientist from open talent platform Kolabtree has supported Israeli medical device manufacturer Inspir Labs. The freelancer, Dr. Nicholas Miceli, carried out a statistical analysis comparing the infection risk for those wearing the new mask against competitive products. Inspir Labs used this analysis to better understand the implications of different silicone and polycarbonate types, mask-face dynamics, and more.

Aerosol-generating procedures (AGPs) create large amounts of small droplets that remain buoyant in the air, which carry a severe risk of infection for patients and healthcare workers. Unlike respiratory droplets, aerosols are small enough to penetrate or circumnavigate most surgical masks. At the start of the pandemic, this risk meant that many hospitals refrained from giving patients non-invasive ventilation (NIV) for fear of infection, leading to more intubations as a result. To combat this, Labs designed an NIV mask that uses a pressure gradient to prevent aerosol emissions from being released into the environment.

“We saw how the pandemic exacerbated the risk caused by aerosol hazards — developing NIV technology that takes into consideration not only the patient, but also the medical staff was the obvious solution,” explained Nadav Nahmias, Chief Technology Officer at Inspir Labs. “During product development, we needed to compare the infection risk for various common viruses in both non-vented and medium-vented hospital wards to see how effective our mask would be. We needed to quantify this information so that we could analyze and present it when applying for regulatory approvals and presenting it to physicians.”

Aerosol-Safe Niv Mask

Inspir Labs posted the project on Kolabtree and was contacted by Dr. Nicholas Miceli, a freelance epidemiology expert. An associate professor of human resource management and healthcare management at Park University in Missouri, Nicholas was previously a researcher at the Ohio Department of Health and had also taught statistics and finite mathematics. This experience provided Nicholas with the necessary skills to carry out a statistical analysis for Inspir Labs, comparing the performance of the new aerosol-safe mask with competitive products.

“Inspir Labs provided me with a journal article that used a specific analytical method and requested that I replicate the analysis with the data provided,” explained Dr Miceli. “Working together with a colleague from Park University’s physics department, I found that the client’s mask performed better than the competition’s.”

Following this important statistical analysis, Inspir Labs progressed into sales processes and regulatory approvals. The mask has now received regulatory approval in Canada, Japan and Israel and is being used as an infection control device in multiple hospitals, keeping healthcare workers safe during AGPs.

Need a freelancer for your medical device project? Post your project for free https://www.kolabtree.com/create-project.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.